title: FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.
authors.affiliation: Baylor University Medical Center, Dallas, Texas.
authors.forename: J W
authors.initials: JW
authors.lastname: Fay
authors.forename: R A
authors.initials: RA
authors.lastname: Nash
authors.forename: J R
authors.initials: JR
authors.lastname: Wingard
authors.forename: D
authors.initials: D
authors.lastname: Przepiorka
authors.forename: R H
authors.initials: RH
authors.lastname: Collins
authors.forename: C
authors.initials: C
authors.lastname: Anasetti
authors.forename: S M
authors.initials: SM
authors.lastname: Devine
authors.forename: L A
authors.initials: LA
authors.lastname: Piñeiro
authors.forename: R F
authors.initials: RF
authors.lastname: Storb
authors.forename: R M
authors.initials: RM
authors.lastname: Aro
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000276:immunology*; D005260:Female; D006086:Graft vs Host Disease / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D015994:Incidence; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010865:Pilot Projects; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D014019:Tissue Donors
chemical_list: D016559:Tacrolimus; D008775:Methylprednisolone; D008727:Methotrexate